Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-22

FDA Approved: LEVETIRACETAM — Supplemental Application (Micro Labs Limited)

View source ↗

Summary

FDA approved a supplemental application for LEVETIRACETAM from Micro Labs Limited (ANDA211954).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)